Key findings from SURMOUNT-1 include a mean weight loss of 15.0% at the 5mg dose, 19.5% at the 10mg dose, and 20.9% at the 15mg dose over 72 weeks
Kassa MG et al
Historically, glucagon was avoided in diabetes treatment because it raises blood sugar
7 mg: white to light yellow, oval shaped debossed with 7 on one side and novo on the other side
Differentiate next-generation GLP-1s by quality of weight loss By Shipra Patel, M.D., Therapeutic Area Lead, Endocrinology, Amy Pace, ScD, Vice President, Biostatistics, Nathan Noakes, Sensor Solutions Director The rise of highly effective glucagon-like peptide-1 receptor agonists (GLP-1s) and multi-agonists has transformed obesity research into a multi-billion-dollar industry with strong momentum and fierce competition
Introduction What if I told you that a single molecule in your body could play a pivotal role in your menstrual cycle